Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of GC1116 H1N1 Vaccine in Healthy Adults
NCT01201902Phase 3Completed
- Sponsor
- GC Biopharma
- Start
- Oct 2009
- Primary completion
- Dec 2009
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of GC-1116 in influenza A/H1N1 (H1N1), sponsored by GC Biopharma. Started Oct 2009; status: completed.
02
Drugs
GC-1116
03
Conditions
influenza A/H1N1 (H1N1)
Beyond the preview
Go deeper on NCT01201902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01201902.